Endo Launches ADRENALIN® Ready-to-Use Premixed Bag, the First and Only FDA-Approved ...
MALVERN, Pa. , Dec. 2, 2024 /CNW/ -- Endo, Inc. (OTCQX: NDOI ) announced today the launch of its ADRENALIN ® (epinephrine in 0.9% sodium chloride injection) ready-to-use premixed bag, the first and ...
来自MSN7 天
Endo Receives FDA Approval for New Sterile Injectable Facility in India
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has secured U.S. Food and Drug Administration (FDA) approval for the commercial ...
pharmaphorum11 年
Endo Health Solutions spends $1.6bn on Paladin Labs acquisition
Key products serve growing drug markets, such as ADHD, pain, urology and allergy. "The acquisition of Paladin Labs accelerates Endo's transformation from an integrated health solutions company to ...
Daily13 天
USFDA approves commercial production of Vasostrict at Endo newest Indore facility
Malvern: Endo, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved commercial production of ...
Pharmabiz13 天
Endo receives US FDA approval for commercial production of Vasostrict at its newest aseptic ...
Endo receives US FDA approval for commercial production of Vasostrict at its newest aseptic manufacturing facility in Indore, India: Our Bureau, Mumbai Tuesday, December 10, 2024, ...
Morningstar13 天
Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
Endo plans to apply for additional product approvals ... We sell different types of products and services to both investment professionals and individual investors. These products and services ...
Endo, Inc.: Endo Receives U.S. FDA Approval of Manufacturing Facility in Indore, India
Endo's sterile injectable production capacityThis marks the site's first U.S. FDA approval Endo is investing and innovating in its Injectable Solutions businessMALVERN ...